Efficient hemostatic sponge and preparation method thereof

A hemostatic sponge, a high-efficiency technology, applied in the field of biomedicine, can solve the problems of unstable hemostatic effect, slow hemostatic speed, local inflammatory response, etc., and achieve the effect of easy process production, enhanced stability, and high hemostatic activity

Active Publication Date: 2017-08-15
GUANGDONG OCEAN UNIVERSITY
View PDF8 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These hemostatic materials are effective in the application of mild bleeding wounds, but the hemostatic effect on severe bleeding wounds is unstable, such as slo...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Efficient hemostatic sponge and preparation method thereof
  • Efficient hemostatic sponge and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Dissolve 3.5 g sodium alginate and 1.5 g sodium hyaluronate in 100 mL of purified water respectively to prepare sodium alginate solution and sodium hyaluronate solution, mix well, add 0.45 g calcium chloride to the mixture, mix well, and statically Set aside for 30 minutes to obtain the inner layer solution, put the inner layer solution into the mold, and pre-freeze at -30°C; then, dissolve 3.5 g of chitosan (molecular weight 50 kDa) with 100 mL of normal saline (0.9% sodium chloride). , deacetylation degree 95%) and 0.1 g polyglutamic acid (molecular weight 1000 kDa), prepare chitosan solution and polyglutamic acid solution, add 0.05 g thrombin to the chitosan solution, mix well, and then Add the polyglutamic acid solution to the chitosan mixed solution, mix well, and let it stand for 30 minutes to obtain the surface layer solution; pour the surface layer solution into the frozen mold containing the inner layer solution, and pre-freeze overnight at -30°C; finally , fre...

Embodiment 2

[0029] Dissolve 3.5 g sodium alginate and 1.0 g sodium hyaluronate in 100 mL of purified water respectively to prepare sodium alginate solution and sodium hyaluronate solution, mix well, add 0.5 g calcium chloride to the mixture, mix well, and statically Set aside for 30 minutes to obtain the inner layer solution, put the inner layer solution into the mold, and pre-freeze at -30°C; then, dissolve 3.8 g of chitosan (molecular weight 20 kDa) with 100 mL of normal saline (0.9% sodium chloride). , deacetylation degree 85%) and 0.29 g polyglutamic acid (molecular weight 700 kDa), prepare chitosan solution and polyglutamic acid solution, add 0.01 g thrombin to the chitosan solution, mix well, and then Add the polyglutamic acid solution to the chitosan mixed solution, mix well, and let it stand for 30 minutes to obtain the surface layer solution; pour the surface layer solution into the frozen mold containing the inner layer solution, and pre-freeze overnight at -30°C; finally , free...

Embodiment 3

[0031] Dissolve 2.0 g sodium alginate and 0.86 g sodium hyaluronate in 100 mL of purified water respectively to prepare sodium alginate solution and sodium hyaluronate solution, mix well, add 0.1 g calcium chloride to the mixture, mix well, and statically Set aside for 30 minutes to obtain the inner layer solution, put the inner layer solution into the mold, and pre-freeze at -30°C; then, dissolve 6.0 g of chitosan (molecular weight 3 kDa) with 100 mL of normal saline (0.9% sodium chloride). , deacetylation degree 75%) and 0.1 g polyglutamic acid (molecular weight 900 kDa), prepare chitosan solution and polyglutamic acid solution, add 0.04 g thrombin to chitosan solution, mix well, and then Add the polyglutamic acid solution to the chitosan mixed solution, mix well, and let it stand for 30 minutes to obtain the surface layer solution; pour the surface layer solution into the frozen mold containing the inner layer solution, and pre-freeze overnight at -30°C; finally , freeze-dr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses efficient hemostatic sponge. The efficient hemostatic sponge is prepared from the following raw materials in percentage by mass: 35%-60% of chitosan, 0.1%-0.5% of thrombin, 1%-3% of polyglutamic acid, 9% of sodium chloride, 20%-35% of sodium alginate, 5%-15% of sodium hyaluronate and 1%-5% of calcium chloride. The efficient hemostatic sponge comprises a surface layer and an inner layer, wherein the surface layer is an antibacterial hemostatic layer containing chitosan, thrombin, polyglutamic acid and sodium chloride; and the inner layer is a gel layer containing sodium alginate, sodium hyaluronate and calcium chloride. The inner layer of the hemostatic sponge is in direct contact with a wound and is capable of absorbing moisture in blood to form gel to block the wound so as to realize primary hemostasis; concentrated blood penetrates through the gel layer to enter the surface layer so as to realize further hemostasis with the combined action of thrombin and chitosan; immobilized thrombin on an outer layer in the hemostatic sponge is capable of enhancing the stability, preserves efficient hemostatic activity and is unlikely to enter blood to cause a thrombus risk; and the efficient hemostatic sponge is particularly applicable to rapid hemostasis of serious bleeding caused by deep wounds, arteriorrhexis and the like.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and more specifically relates to a high-efficiency hemostatic sponge and a preparation method thereof. Background technique [0002] In the hemostasis in trauma treatment of sudden accidents and clinical operations, especially in the on-site rescue of injured persons in wars, rapid and efficient hemostasis can effectively reduce casualties and alleviate later complications. Traditional hemostatic materials have unsatisfactory hemostatic effects on wounds such as irregular shapes, deep, narrow, and ruptured arteries. Therefore, there is a need for a fast, safe and efficient hemostatic material suitable for on-site and clinical first aid to replace traditional hemostatic materials. [0003] Chitosan is a natural biological polysaccharide produced after deacetylation of chitin. It is the only alkaline polysaccharide in nature so far, and its natural resources are very rich. Due to its excellen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L24/08A61L24/10A61L24/06A61L24/02A61L24/00
CPCA61L24/0015A61L24/02A61L24/06A61L24/08A61L24/10A61L2300/232A61L2300/254A61L2300/418A61L2400/04C08L5/08C08L5/04C08L89/00C08L77/04
Inventor 胡章李思东洪鹏志程瑜黄娜廖铭能孔松芝
Owner GUANGDONG OCEAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap